160 related articles for article (PubMed ID: 2444245)
41. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.
Embury SH; Dozy AM; Miller J; Davis JR; Kleman KM; Preisler H; Vichinsky E; Lande WN; Lubin BH; Kan YW; Mentzer WC
N Engl J Med; 1982 Feb; 306(5):270-4. PubMed ID: 6172710
[TBL] [Abstract][Full Text] [Related]
42. Intracellular hemoglobin S polymerization and the clinical severity of sickle cell anemia.
Poillon WN; Kim BC; Castro O
Blood; 1998 Mar; 91(5):1777-83. PubMed ID: 9473246
[TBL] [Abstract][Full Text] [Related]
43. Hydroxyurea alters hematological, biochemical and inflammatory biomarkers in Brazilian children with SCA: Investigating associations with βS haplotype and α-thalassemia.
Yahouédéhou SCMA; da Guarda CC; Figueiredo CVB; Santiago RP; Carvalho SP; Fiuza LM; Ndidi US; Oliveira RM; Carvalho MOS; Nascimento VML; Rocha LC; Lyra IM; Adorno EV; Goncalves MS
PLoS One; 2019; 14(7):e0218040. PubMed ID: 31306416
[TBL] [Abstract][Full Text] [Related]
44. The haematological, biochemical and clinical--presentation of haemoglobin S in Saudi Arabia (i). Haematological & clinical expression.
El-Hazmi MA; Jabbar FA; Al-Faleh FZ; Al-Swailem AR; Warsy AS
Trop Geogr Med; 1987 Apr; 39(2):157-62. PubMed ID: 3629709
[TBL] [Abstract][Full Text] [Related]
45. Alpha thalassaemia and the haematology of normal Jamaican children.
Maude GH; Higgs DR; Beckford M; Grandison Y; Mason K; Taylor B; Serjeant BE; Serjeant GR
Clin Lab Haematol; 1985; 7(4):289-95. PubMed ID: 2420505
[TBL] [Abstract][Full Text] [Related]
46. The pharmacological manipulation of fetal haemoglobin: trials using hydroxyurea and recombinant human erythropoietin.
el-Hazmi MA; al-Momen A; Warsy AS; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F
Acta Haematol; 1995; 93(2-4):57-61. PubMed ID: 7543719
[TBL] [Abstract][Full Text] [Related]
47. The haematology of homozygous sickle cell disease after the age of 40 years.
Morris J; Dunn D; Beckford M; Grandison Y; Mason K; Higgs D; De Ceulaer K; Serjeant B; Serjeant G
Br J Haematol; 1991 Mar; 77(3):382-5. PubMed ID: 1707292
[TBL] [Abstract][Full Text] [Related]
48. 5-Azacytidine increases HbF production and reduces anemia in sickle cell disease: dose-response analysis of subcutaneous and oral dosage regimens.
Dover GJ; Charache S; Boyer SH; Vogelsang G; Moyer M
Blood; 1985 Sep; 66(3):527-32. PubMed ID: 2411310
[TBL] [Abstract][Full Text] [Related]
49. The interaction of alpha thalassaemia and sickle cell-beta zero thalassaemia.
Vyas P; Higgs DR; Weatherall DJ; Dunn D; Serjeant BE; Serjeant GR
Br J Haematol; 1988 Dec; 70(4):449-54. PubMed ID: 3219294
[TBL] [Abstract][Full Text] [Related]
50. Homozygous sickle cell disease in Uganda and Jamaica a comparison of Bantu and Benin haplotypes.
Ndugwa C; Higgs D; Fisher C; Hambleton I; Mason K; Serjeant BE; Serjeant GR
West Indian Med J; 2012 Oct; 61(7):684-91. PubMed ID: 23620965
[TBL] [Abstract][Full Text] [Related]
51. Absolute Reticulocyte Count Acts as a Surrogate for Fetal Hemoglobin in Infants and Children with Sickle Cell Anemia.
Meier ER; Byrnes C; Weissman M; Lee YT; Miller JL
PLoS One; 2015; 10(9):e0136672. PubMed ID: 26366562
[TBL] [Abstract][Full Text] [Related]
52. Fetal haemoglobin production and the sickle gene in the oases of Eastern Saudi Arabia.
Pembrey ME; Wood WG; Weatherall DJ; Perrine RP
Br J Haematol; 1978 Nov; 40(3):415-29. PubMed ID: 749927
[TBL] [Abstract][Full Text] [Related]
53. Ultrasonographic spleen size and haematological parameters in children with sickle cell anaemia in Kano, Nigeria.
Abdullahi SU; Hassan-Hanga F; Ibrahim M
Niger Postgrad Med J; 2014 Jun; 21(2):165-70. PubMed ID: 25126872
[TBL] [Abstract][Full Text] [Related]
54. Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patients.
Conran N; Oresco-Santos C; Acosta HC; Fattori A; Saad ST; Costa FF
Br J Haematol; 2004 Feb; 124(4):547-54. PubMed ID: 14984506
[TBL] [Abstract][Full Text] [Related]
55. Alpha thalassemia and the hematology of homozygous sickle cell disease in childhood.
Stevens MC; Maude GH; Beckford M; Grandison Y; Mason K; Taylor B; Serjeant BE; Higgs DR; Teal H; Weatherall DJ
Blood; 1986 Feb; 67(2):411-4. PubMed ID: 2417644
[TBL] [Abstract][Full Text] [Related]
56. Improvement of sickle cell anemia by iron-limited erythropoiesis.
Castro O; Poillon WN; Finke H; Massac E
Am J Hematol; 1994 Oct; 47(2):74-81. PubMed ID: 7522396
[TBL] [Abstract][Full Text] [Related]
57. The relationship between fetal hemoglobin and disease severity in children with sickle cell anemia.
Odenheimer DJ; Sarnaik SA; Whitten CF; Rucknagel DL; Sing CF
Am J Med Genet; 1987 Jul; 27(3):525-35. PubMed ID: 2443006
[TBL] [Abstract][Full Text] [Related]
58. Fetal hemoglobin and potassium in isolated transferrin receptor-positive dense sickle reticulocytes.
Franco RS; Barker-Gear R; Miller MA; Williams SM; Joiner CH; Rucknagel DL
Blood; 1994 Sep; 84(6):2013-20. PubMed ID: 7521697
[TBL] [Abstract][Full Text] [Related]
59. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
[TBL] [Abstract][Full Text] [Related]
60. A comparison of sickle cell syndromes in northern Greece.
Christakis J; Vavatsi N; Hassapopoulou H; Angeloudi M; Papadopoulou M; Loukopoulos D; Morris JS; Serjeant BE; Serjeant GR
Br J Haematol; 1991 Mar; 77(3):386-91. PubMed ID: 2012764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
